BNCT – Page 2 – STELLA PHARMA CORPORATION

STELLA PHARMA NEWS

BNCT

Press Release BNCT

March 4th, 2024

Interim Analysis Results of Post-Marketing Surveillance of Our Drug Product published ― Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer

The results regarding safety and effectiveness of our product Borofalan(10B), u……

Press Release BNCT

January 11th, 2024

Investigator-initiated Phase I BNCT clinical trial for newly diagnosed glioblastoma

We would like to announce that Phase I clinical trial for newly diagnosed gliob……

BNCT SPM-011 Information

December 25th, 2023

Orphan Drug designation for Borofalan (10B) (SPM-011) as treatment of Cutaneous Angiosarcoma

Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……

Press Release BNCT

December 13th, 2023

Stella Pharma, Mitsubishi Chemical Group, and the University of Tokyo conclude Joint Research Agreement—Accelerating practical application of polyvinyl alcohol (PVA) for boron neutron capture therapy (BNCT)—

Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……

BNCT Information

December 6th, 2023

Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy

Business France Japan Office of the French Embassy in Japan engages in building……

Press Release BNCT

June 24th, 2022

Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China

Sumitomo Heavy Industries, Ltd. and STELLA PHARMA CORPORATION have respectively……

BNCT Information

February 18th, 2022

“Destroying Cancer with Boron and Neutrons” will be on NHK WORLD-JAPAN

Japan's public media organization NHK (Japan Broadcasting Corporation) will bro……

BNCT Information

October 21st, 2021

Interview published on Science Japan, online magazine| Japan’s “Fifth Cancer Treatment,” BNCT, Finally Off the Ground

Here is a featured story on BNCT (Boron Neutron Capture Therapy) boron drug dev……

BNCT Information

June 23rd, 2021

The phase II study of recurrent glioblastoma in Japan has published in “Neuro-Oncology Advances”

The title is “Accelerator-based BNCT for patients with recurrent glioblastoma: ……

BNCT Information

December 9th, 2020

The phase II study of recurrent or locally advanced head and neck cancer in Japan has published in “Radiotherapy and Oncology”

The title is "Boron neutron capture therapy using cyclotron-based epithermal ne……